Company Filing History:
2 out of 1,716 
1 out of 13 Years Active: 2003-2020
Title: Innovations by Jang-Ming Lee
Introduction
Jang-Ming Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in the area of cancer treatment. With a total of three patents to his name, his work focuses on improving patient outcomes through innovative methods.
Latest Patents
One of his latest patents is an optical method for predicting treatment response, survival, and recurrence of esophageal cancer patients. This invention analyzes the spectral signatures of a patient's tumor tissue spectra, achieving a sensitivity of 75% and specificity of 73.3% in concurrent chemoradiotherapy (CCRT) response. Additionally, the survival prediction rate reaches a sensitivity of 100%, while the recurrence prediction rate achieves a sensitivity of 85.7%. Another notable patent involves biomarkers for predicting the response of esophageal cancer patients to chemoradiotherapy. This invention relates to novel genetic markers associated with a patient's response to chemoradiation therapy, providing methods and kits for predicting outcomes through genotyping.
Career Highlights
Jang-Ming Lee has worked with esteemed institutions such as National Taiwan University and the Animal Technology Institute Taiwan. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
He has collaborated with notable colleagues, including Pei-Wen Yang and Ching-Fu Tu, to further enhance his research and inventions.
Conclusion
Jang-Ming Lee's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents reflect a commitment to improving patient care and outcomes through advanced technology.